NA
NEPH icon

Navellier & Associates’s Nephros NEPH Stock Holding History

Navellier & Associates’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57K Sell
19,126
-8,049
-30% -$32.1K 0.01% 326
2025
Q4 		$133K Buy
+27,175
New +$139K 0.01% 322

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Cornerstone Capital Palo Alto, California $1B AUM 21.47% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Navellier & Associates's NEPH Position: Q1 2026 in Review

Navellier & Associates reduced its Nephros (NEPH) stake by 30% in Q1 2026, selling an estimated $32.1K and leaving 19,126 shares worth $57K. The position accounts for 0.01% of the portfolio, ranked #326.

Navellier & Associates first reported a position in NEPH in Q4 2025 and has held it in 2 quarters since. The position peaked at $133K in Q4 2025. 27 funds tracked by Wall St. Rank hold NEPH as of Q1 2026.

  • Navellier & Associates held 19,126 shares of Nephros worth $57K as of Q1 2026.
  • Navellier & Associates sold 8,049 Nephros shares in Q1 2026, an estimated $32.1K.
  • Nephros made up 0.01% of Navellier & Associates's portfolio in Q1 2026, its #326 holding.
  • Navellier & Associates first reported a position in Nephros in Q4 2025 and has held it in 2 quarters since.
  • Navellier & Associates's Nephros position peaked at $133K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Nephros as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.